US-based medical device company Natus has agreed with GN Store Nord to acquire GN Otometrics from GN Hearing for $145m.

Otometrics manufactures computer-based audiological, otoneurologic and vestibular instrumentation and sound rooms for hearing and balance care professionals worldwide.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Generating annual revenue of about $110m, the company’s portfolio is characterised with sophisticated design technology catering to the hearing and balance assessment markets. Its global brands are Aurical, ICS and Madsen.

“The agreement between Natus and GN Hearing will see the companies collaborate on future technology, product development and commercialisation.”

Natus president and CEO Jim Hawkins said: “Otometrics has several leading brands and has introduced many industry firsts.

“With the addition of Otometrics, we anticipate Natus revenue in 2017 will reach $500m, a major milestone for the company.  We expect Otometrics to be accretive to our 2017 earnings with a non-GAAP contribution operating margin goal for the year of 10% and a 2018 goal of 20%.”

The agreement between Natus and GN Hearing will see the companies collaborate on future technology, product development and commercialisation.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Natus will also assume rights to fully commercialise the complete digital ear scanning solution, OTOSCAN, sharing future royalties with GN Hearing.

OTOSCAN has been designed to offer an easy way of custom hearing care to clients. It is intuitive and enables quick and safe earscans while ensuring accuracy.

In order to fund the acquisition, Natus has entered into a $150m revolving credit agreement with JP Morgan Chase and Citibank, and is planning to use offshore cash and proceeds from this credit line to fund the potential acquisition.

The transaction is expected to be completed at the end of this year.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact